Browsing: Clinical Mortality
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for clinical mortality analysis, commentary and insights.
The past four decades have brought revolutionary improvements in cancer care, transforming many forms of cancer from fatal diagnoses into chronic, manageable conditions.
For those in the longevity and mortality modelling game, 2025 has provided plenty of activity to keep the actuaries busy. Greg Winterton spoke to James Hadley, Senior Consultant at Barnett Waddingham, to learn more about what is front and centre of the conversation in his world as the year draws to a close.
Under optimistic scenarios, new research from Swiss Re projects that GLP-1 medications could reduce all-cause mortality in the US by as much as 6.4% by 2045. But what will the impact be on the life settlement market?
The success story of rising life expectancy is far from over, but it is evolving. For pensions and insurance, the challenge is to reflect short-term headwinds without losing sight of long-term potential.
Longevity and Mortality Investor (LMI) is the new name for Life Risk News. Greg Winterton caught up with Chris Wells, Managing Editor at LMI, to discuss the reasons behind the rebrand, his thoughts on how the longevity and mortality markets have evolved in recent years, and plans for the future.
A recent article in The Lancet Public Health suggests that walking 7,000 steps is associated with reductions in the risk of several serious health outcomes.
Two areas of research are providing the gerontology community with the most promise: dysregulated nutrient sensing and cell senescence.
General mortality trend in England continues downwards but certain diseases getting worse.
Advances in early detection and treatment have significantly improved survival outcomes, especially in non-metastatic cases. However, prognosis varies greatly depending on the stage at diagnosis, molecular characteristics, and the extent of metastasis.
Life Risk News Q&A: Matthew Sheridan of Health Data Analytics Institute to get his thoughts on how predictive modelling is helping US health systems to better triage patients and model risk.